Elsevier, a global leader in information and data analytics, has signed a multi-year agreement with Iktos, a company specializing in artificial intelligence for new Drug Discovery. The partnership will strengthen Elsevier’s flagship chemistry solution, Reaxys, by combining the company’s high-quality chemistry data with synthetic planning AI technologies developed by Iktos to accelerate chemistry research for […]

The post Elsevier and Iktos partner to deliver an AI-driven synthetic chemistry platform for drug discovery first appeared on World Pharma Today.